The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Histopathologic and immunohistochemical findings in triple-negative breast cancers showing clinical progressive disease during neoadjuvant chemotherapy.
Yuko Tanabe
No relevant relationships to disclose
Hitoshi Tsuda
No relevant relationships to disclose
Masayuki Yoshida
No relevant relationships to disclose
Takayuki Kinoshita
No relevant relationships to disclose
Makoto Kodaira
No relevant relationships to disclose
Mayu Yunokawa
No relevant relationships to disclose
Kan Yonemori
No relevant relationships to disclose
Harukaze Yamamoto
No relevant relationships to disclose
Chikako Shimizu
No relevant relationships to disclose
Yasuhiro Fujiwara
No relevant relationships to disclose
Kenji Tamura
No relevant relationships to disclose